Why the study?
Does admission hyperglycemia increase in-hospital mortality in patients with hip fracture?
Does admission hyperglycemia increase in-hospital mortality in patients with hip fracture?
Admission hyperglycemia (>140 mg/dl) is a prognostic indicator for higher in-hospital mortality in patients with hip fracture.
Admission hyperglycemia was associated with higher hip fracture mortality; leaves open whether glucose control improves outcomes.
OBJECTIVE: To determine the proportion of hip-fracture patients with admission hyperglycaemia, and, when present, whether it was associated with a worse outcome (i.e. increased length of hospital stay, admission to ICU, or mortality). PATIENTS AND METHODS: Over a 2-year period, we retrospectively analysed records of patients with a primary diagnosis of hip fracture (ICD-9-CM 820.x). The records were retrieved from an electronic hospital database. RESULTS: An admission blood sugar level (aBSL) greater than 140 mg/dl was observed in 34% of the patients and was associated with a higher in-hospital mortality (P=0.042). ICU admissions and length of stay did not differ for patients having an aBSL above or below the 140 mg/dl cut-off. CONCLUSION: Hyperglycaemia is common in hip-fracture patients. A high aBSL might serve as a prognostic indicator in hip-fracture patients. To our knowledge, this is the first report of hyperglycaemia-associated mortality in less severely traumatised patients, who generally are not admitted to an ICU.
No takes yet. Share an insight, caveat, or question.
Leto et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: